Clinical trial

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

NCT00078390 · Shionogi, Industry · Completed

Key facts

NCT number NCT00078390
Title Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
Official title A Phase I/II Study of the Safety, Pharmacokinetic Interaction and Efficacy of S-3304 in Combination With Standard Therapy in Patients With Locally Advanced Non-small Cell Lung Cancer.
Lead sponsor Shionogi, Industry
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Non Small Cell Lung Cancer, Lung Cancer, Stage IIIA Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer
Intervention type Drug, Other
Interventions S-3304, Chemo-irradiation
Enrollment 9
Start date Feb 1, 2003
Primary completion Sep 28, 2006
Completion Oct 26, 2006
First posted Feb 26, 2004
Last update posted May 2, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies